| Project Detail |
Location: Greece Project number: 55619 Business sector: Manufacturing and Services Notice type: Private Environmental category: B Approval date: 26 Jul 2024 Status: Disbursing English-language PSD published: 21 Oct 2024 Equity co-investment of up to EUR 25 million, alongside Mid Europa, for the acquisition of Famar (the Company or the Target), a European pharmaceutical Contract Development and Manufacturing Organisation (CDMO). Project Objectives The Banks equity investment alongside Mid Europa will enable the transformation of Famar towards higher-value-added products with an enhanced set of R&D capabilities, and a potential for the Company to become a platform for further acquisitions in the Central and South Eastern Europe region. |
